Hollingsworth, Robert E.

Turning the corner on therapeutic cancer vaccines

Hollingsworth, R. E., & Jansen, K. (2019) · npj Vaccines

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 689

A New Bliss Independence Model to Analyze Drug Combination Data

Zhao, W., Sachsenmeier, K., Zhang, L., Sult, E., Hollingsworth, R. E., & Yang, H. (2014) · SLAS Discovery

Computational Drug Discovery MethodsStatistical Methods in Clinical Trials

Cited by 322

Interleukin-6 Stimulates Defective Angiogenesis

Gopinathan, G., Milagre, C., Pearce, O. M. T., Reynolds, L. E., Hodivala-Dilke, K., Leinster, D. A., Zhong, H., Hollingsworth, R. E., Thompson, R., Whiteford, J. R., et al. (2015) · Cancer Research

Angiogenesis and VEGF in CancerLymphatic System and Diseases

Cited by 249

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor‐initiating cell frequency

Dosch, J., Ziemke, E., Wan, S., Luker, K., Welling, T., Hardiman, K., Fearon, E., Thomas, S., Flynn, M., Rios-Doria, J., et al. (2017) · Oncotarget

Protease and Inhibitor MechanismsCancer Cells and Metastasis

Cited by 40